3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
24
Pancreatic Cyst
5
Esophageal Neoplasms
4
Pancreatic adenoma
2
Lymphadenopathy
2
Gastrointestinal Neoplasms
2
Cysts
2
Arachnodactyly
2
Adenoma, Islet Cell
2
Subepithelial Gastrointestinal Tumors
1
Stomach Neoplasms
1
Peutz-Jeghers Syndrome
1
Pancreatitis, Chronic
1
Pancreatic carcinoma, familial
1
Pancreatic Intraductal Neoplasms
1
Pancreatic Cystic Neoplasm
1
Other Specified Disorders of Esophagus, Stomach or Duodenum
1
Neoplasms, Unknown Primary
1
Neoplasm Metastasis
1
Lymphatic Metastasis
1
Hereditary pancreatitis
1
Gastrointestinal Stromal Tumor of Stomach
1
Esophagus
1
Dysplastic Nevus Syndrome
1
Duodenal Neoplasms
1
Disease
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colorectal Neoplasms
1
Cholangitis, Sclerosing
1
Cholangiocarcinoma
1
Interventions
Gemcitabine
113
Cisplatin
77
Oxaliplatin
46
pembrolizumab
35
Fluorouracil
33
Capecitabine
31
durvalumab
27
Leucovorin
27
lenvatinib
26
Magnetic Resonance Spectroscopy
15
Irinotecan
14
Drug Therapy
13
Biopsy
13
Nivolumab
12
Albumin-Bound Paclitaxel
12
tislelizumab
11
Specimen Handling
11
Radiofrequency Ablation
11
130-nm albumin-bound paclitaxel
11
pemigatinib
10
apatinib
10
Taxes
10
Radiotherapy
10
Floxuridine
10
Folfox protocol
9
Bevacizumab
9
S 1 (combination)
8
Platinum
8
Photochemotherapy
8
Liver Transplantation
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
Endoscopic Ultrasound-Guided Fine Needle Aspiration
×
Gastrointestinal
×
Clear all
NCT05187312
2024-04-12
ERDB
Region Stockholm
Recruiting
1,000 enrolled